Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Optimization of cGMP purification and expansion of umbilical cord blood-derived T-regulatory cells in support of first-in-human clinical trials.

McKenna DH Jr, Sumstad D, Kadidlo DM, Batdorf B, Lord CJ, Merkel SC, Koellner CM, Curtsinger JM, June CH, Riley JL, Levine BL, Miller JS, Brunstein CG, Wagner JE, Blazar BR, Hippen KL.

Cytotherapy. 2017 Feb;19(2):250-262. doi: 10.1016/j.jcyt.2016.10.011. Epub 2016 Nov 22.

2.

Clinical production and therapeutic applications of alloreactive natural killer cells.

McKenna DH, Kadidlo DM, Cooley S, Miller JS.

Methods Mol Biol. 2012;882:491-507. doi: 10.1007/978-1-61779-842-9_28.

PMID:
22665252
3.

Successful "in-flight" activation of natural killer cells during long-distance shipping.

Koepsell SA, Kadidlo DM, Fautsch S, McCullough J, Klingemann H, Wagner JE, Miller JS, McKenna DH Jr.

Transfusion. 2013 Feb;53(2):398-403. doi: 10.1111/j.1537-2995.2012.03695.x. Epub 2012 May 11.

4.

Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity.

Hippen KL, Merkel SC, Schirm DK, Sieben CM, Sumstad D, Kadidlo DM, McKenna DH, Bromberg JS, Levine BL, Riley JL, June CH, Scheinberg P, Douek DC, Miller JS, Wagner JE, Blazar BR.

Sci Transl Med. 2011 May 18;3(83):83ra41. doi: 10.1126/scitranslmed.3001809.

5.

Good manufacturing practices production of natural killer cells for immunotherapy: a six-year single-institution experience.

McKenna DH Jr, Sumstad D, Bostrom N, Kadidlo DM, Fautsch S, McNearney S, Dewaard R, McGlave PB, Weisdorf DJ, Wagner JE, McCullough J, Miller JS.

Transfusion. 2007 Mar;47(3):520-8.

PMID:
17319835
6.

The Minnesota Molecular and Cellular Therapeutics Facility: a state-of-the-art biotherapeutics engineering laboratory.

McKenna DH, Kadidlo DM, Miller JS, Orchard PJ, Wagner JE, McCullough J.

Transfus Med Rev. 2005 Jul;19(3):217-28.

PMID:
16010652
7.

Cellular engineering of HSV-tk transduced, expanded T lymphocytes for graft-versus-host disease management.

Burger SR, Kadidlo DM, Basso L, Bostrom N, Orchard PJ.

Acta Haematol. 2003;110(2-3):121-31. Review.

PMID:
14583672

Supplemental Content

Loading ...
Support Center